Steve Miller - 09 Dec 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
09 Dec 2024
Net transactions value
-$895,850
Form type
4
Filing time
11 Dec 2024, 17:00:29 UTC
Previous filing
25 Nov 2024
Next filing
17 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise +11,872 +1.8% 686,996 09 Dec 2024 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $200,500 +50,000 +7.3% $4.01 736,996 10 Dec 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $1,096,350 -50,000 -6.8% $21.93 686,996 10 Dec 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Restricted Stock Units Options Exercise $0 -11,872 -0.64% $0.000000 1,837,176 09 Dec 2024 Common Stock 11,872 Direct F1, F4, F5
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -2.7% $0.000000 1,787,176 10 Dec 2024 Common Stock 50,000 $4.01 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F3 Represents a weighted average price for the shares sold. Shares were sold in a range between $21.73 and $22.09 per share.
F4 Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
F5 Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 9, 2024.
F6 Options vested in three annual tranches beginning on January 2, 2019.